Insider at

04

Insider transactions

05
0 buys (P) 0 sells (S) Net: $0 + 5 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

5 other filings hidden
DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
Dec. 10, 2019 AVTX P 2,913 $2.85 $8,302 52,462 Direct +5.88% Acquired -99.8% (price as of 2026-10-02)
June 10, 2019 AVTX P 4,549 $2.85 $12,965 49,549 Direct +10.11% Acquired -99.8% (price as of 2026-10-02)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
May 24, 2019 AVTX Stock Option (Right to Buy) Common Stock (25,000) $4.98 May 24, 2029 25,000 Acquired
April 1, 2019 AVTX Stock Option (Right to Buy) Common Stock (175,000) $6.22 April 1, 2029 175,000 Acquired
July 16, 2018 AVTX Stock Option (Right to Buy) Common Stock (80,000) $4.26 July 15, 2028 80,000 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Compensation (DEF 14A)

08

Matched by name from proxy statements (DEF 14A) — verify against the filing.

AVTX

Ph.D. (5) Former Chief Scientific Officer
Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2019 $324,167 $140,000 $224,100 $657,095 · · · $1,345,362

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.